A Phase 1 Study to Evaluate the Tolerance, Safety, Pharmacokinetics and Pharmacodynamics of Oral Administration of SSS17 in Chinese Healthy Adult Subjects With Single and Multiple Dose Escalation and the Effect of Food on the Pharmacokinetics of SSS17
Latest Information Update: 06 Dec 2023
Price :
$35 *
At a glance
- Drugs SSS 17 (Primary)
- Indications Anaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Shenyang Sunshine Pharmaceutical
- 27 Dec 2021 Status changed from not yet recruiting to recruiting.
- 21 May 2021 New trial record